Mechanism of action

The mechanism of action (MOA) is the specific sequence of molecular events through which a substance produces its effects — which biological targets it engages, how that engagement changes those targets, and what cascade of physiological and psychological consequences follows. It is the pharmacological explanation behind a drug's action, distinct from a simple list of its observed effects.

Biological targets include receptors, enzymes, ion channels, and transporters. A substance may act with high selectivity on a single target type, or it may engage several systems at once; that breadth shapes both the range of its effects and the complexity of its interactions with other drugs.

How it works · its role

Mechanisms fall into a few broad categories. An agonist activates a receptor; an antagonist occupies and blocks it. An enzyme inhibitor slows a metabolic process; a transporter blocker allows a neurotransmitter to accumulate in the synapse rather than being cleared. Most psychoactive substances act through some combination of these basic operations.

The chain from molecular target to lived experience is rarely direct. A compound binding one receptor subtype may shift neurotransmitter release, alter regional brain activity, and produce effects that seem unrelated to each other — sedation, pain suppression, and euphoria from a single receptor family, for example. Mechanism of action attempts to account for each step in that chain.

For many compounds, especially poorly-studied or novel ones, the full mechanism is not yet established. Effects and risks may then be inferred from structural analogy with better-studied relatives, or from receptor-binding profiles alone. That reasoning is useful but limited: a shared mechanism does not guarantee a shared outcome, and such inferences are identified as such on these pages.

Relevance to substances & effects

Knowing a substance's mechanism helps anticipate effects, identify interaction risks, and understand why certain drug combinations are flagged. Two substances acting on the same target or pathway can reinforce or compete with each other in ways that follow directly from the mechanism.

Substance classes often cluster around mechanisms. Opioids act at opioid receptors; classic psychedelics act at the 5-HT₂A receptor; stimulants act on monoamine transporters. Understanding these groupings explains cross-tolerance — when one agonist downregulates a receptor family, another agonist at the same site finds a blunted response.

Mechanism also underlies the interaction warnings on substance pages. Two drugs competing for the same metabolic enzyme may each reach higher-than-expected levels in the body. Mechanism is the first-principles reason behind those flags; the interaction layer supplies the specific severity assessments with their sources.